Michael Howell

Also affiliated with The Francis Crick Institute, University of California San Diego, Electronic BioSciences (United States)

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Ruxolitinib for the treatment of steroid-refractory acute GVHD (REACH1): a multicenter, open-label phase 2 trial”.

Ruxolitinib for the treatment of steroid-refractory acute GVHD (REACH1): a multicenter, open-label phase 2 trial

Blood(2020)10.1182/blood.2020004823

N/A

7.0DataRank · unranked

307 citations

Miguel‐Angel Perales, Mark A. Schroeder, Haris Ali, Nirav N. Shah, Yi‐Bin Chen +8 more

394 Gene expression based molecular test proves clinical validity as diagnostic aid for the differential diagnosis of psoriasis and eczema in formalin fixed and paraffin embedded tissue

British Journal of Dermatology(2023)10.1093/bjd/ljad162.019

N/A

0.104DataRank · unranked

1 citations

Anais Doll, Deniz Uereyener, Sophie Roenneberg, Christina Hillig, Lucca Weber +18 more

Postbariatric hypoglycemia: symptom patterns and associated risk factors in the Longitudinal Assessment of Bariatric Surgery study

Surgery for Obesity and Related Diseases(2021)10.1016/j.soard.2021.04.021

N/A

0DataRank · unranked

37 citations

Bruce M. Wolfe, Nora F. Fino, Miriam Elman, David R. Flum, James E. Mitchell +75 more